Skip to main content

Table 2 Clinical Characteristics of Immune Subtypes

From: Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

GSE62254

GSE29272

 

Immunity L

Immunity M

Immunity H

 

Immunity L

Immunity M

Immunity H

 

No.

%

No.

%

No.

%

 

No.

%

No.

%

No.

%

Age

Age

< 60

10

9.4%

79

74.5%

17

16.0%

< 60

11

16.4%

41

61.2%

15

22.4%

≥60

22

11.6%

140

74.1%

27

14.3%

≥60

7

11.9%

48

81.4%

4

6.8%

Gender

Gender

Male

24

12.3%

143

73.3%

28

14.4%

Male

14

14.1%

70

70.7%

15

15.2%

Female

8

8.0%

76

76.0%

16

16.0%

Female

4

14.8%

19

70.4%

4

14.8%

pStage

pStage

I/II

14

11.3%

93

75.0%

17

13.7%

I/II

2

20.0%

8

80.0%

0

0.0%

III/IV

18

10.5%

126

73.7%

27

15.8%

III/IV

16

13.8%

81

69.8%

19

16.4%

Metastasis

 Yes

16

11.3%

110

77.5%

16

11.3%

       

 No

16

10.5%

109

71.2%

28

18.3%

      Â